Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Adenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds.

Marín-Aguilar F, Pavillard LE, Giampieri F, Bullón P, Cordero MD.

Int J Mol Sci. 2017 Jan 29;18(2). pii: E288. doi: 10.3390/ijms18020288. Review.

2.

Unraveling the Anticancer Effect of Curcumin and Resveratrol.

Pavan AR, Silva GD, Jornada DH, Chiba DE, Fernandes GF, Man Chin C, Dos Santos JL.

Nutrients. 2016 Nov 10;8(11). pii: E628. Review.

3.

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS.

J Neurosurg. 2016 Jul 15:1-13. doi: 10.3171/2016.1.JNS152077. [Epub ahead of print]

PMID:
27419830
4.

Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer.

Shindikar A, Singh A, Nobre M, Kirolikar S.

J Oncol. 2016;2016:9750785. doi: 10.1155/2016/9750785. Epub 2016 May 8. Review.

5.

Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential.

Feeley KP, Bray AW, Westbrook DG, Johnson LW, Kesterson RA, Ballinger SW, Welch DR.

Cancer Res. 2015 Oct 15;75(20):4429-36. doi: 10.1158/0008-5472.CAN-15-0074.

6.

Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells.

van Ginkel PR, Yan MB, Bhattacharya S, Polans AS, Kenealey JD.

Toxicol Appl Pharmacol. 2015 Nov 1;288(3):453-62. doi: 10.1016/j.taap.2015.08.016. Epub 2015 Sep 1.

7.

Resveratrol and cancer: Challenges for clinical translation.

Singh CK, Ndiaye MA, Ahmad N.

Biochim Biophys Acta. 2015 Jun;1852(6):1178-85. doi: 10.1016/j.bbadis.2014.11.004. Epub 2014 Nov 8. Review.

8.

The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.

Colin DJ, Limagne E, Ragot K, Lizard G, Ghiringhelli F, Solary É, Chauffert B, Latruffe N, Delmas D.

Cell Death Dis. 2014 Nov 20;5:e1533. doi: 10.1038/cddis.2014.486.

9.

The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.

Kanavi MR, Darjatmoko S, Wang S, Azari AA, Farnoodian M, Kenealey JD, van Ginkel PR, Albert DM, Sheibani N, Polans AS.

Molecules. 2014 Oct 30;19(11):17578-603. doi: 10.3390/molecules191117578.

10.

Targeted nanoparticles for pediatric leukemia therapy.

Basha R, Sabnis N, Heym K, Bowman WP, Lacko AG.

Front Oncol. 2014 May 13;4:101. doi: 10.3389/fonc.2014.00101. eCollection 2014. Review.

11.

Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration.

Kumar A, Hu J, LaVoie HA, Walsh KB, DiPette DJ, Singh US.

BMC Cancer. 2014 Apr 11;14:256. doi: 10.1186/1471-2407-14-256. Erratum in: BMC Cancer. 2016;16(1):609.

12.

Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis.

Ortega I, Villanueva JA, Wong DH, Cress AB, Sokalska A, Stanley SD, Duleba AJ.

J Ovarian Res. 2014 Feb 13;7:21. doi: 10.1186/1757-2215-7-21.

13.

Protective effect of resveratrol on biomarkers of oxidative stress induced by iron/ascorbate in mouse spermatozoa.

Mojica-Villegas MA, Izquierdo-Vega JA, Chamorro-Cevallos G, Sánchez-Gutiérrez M.

Nutrients. 2014 Jan 27;6(2):489-503. doi: 10.3390/nu6020489.

14.

Resveratrol attenuates cisplatin renal cortical cytotoxicity by modifying oxidative stress.

Valentovic MA, Ball JG, Brown JM, Terneus MV, McQuade E, Van Meter S, Hedrick HM, Roy AA, Williams T.

Toxicol In Vitro. 2014 Mar;28(2):248-57. doi: 10.1016/j.tiv.2013.11.001. Epub 2013 Nov 12.

15.

Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects.

Bharali DJ, Siddiqui IA, Adhami VM, Chamcheu JC, Aldahmash AM, Mukhtar H, Mousa SA.

Cancers (Basel). 2011 Oct 26;3(4):4024-45. doi: 10.3390/cancers3044024.

16.

Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.

Yu XM, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H.

Mol Cancer Ther. 2013 Jul;12(7):1276-87. doi: 10.1158/1535-7163.MCT-12-0841. Epub 2013 Apr 17.

17.

Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.

Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O.

Int J Nanomedicine. 2012;7:1841-50. doi: 10.2147/IJN.S29710. Epub 2012 Apr 11.

18.

Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary.

Morita Y, Wada-Hiraike O, Yano T, Shirane A, Hirano M, Hiraike H, Koyama S, Oishi H, Yoshino O, Miyamoto Y, Sone K, Oda K, Nakagawa S, Tsutsui K, Taketani Y.

Reprod Biol Endocrinol. 2012 Feb 23;10:14. doi: 10.1186/1477-7827-10-14.

19.

Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.

Soto BL, Hank JA, Darjatmoko SR, Polans AS, Yanke EM, Rakhmilevich AL, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM.

Int Immunopharmacol. 2011 Nov;11(11):1877-86. doi: 10.1016/j.intimp.2011.07.019. Epub 2011 Aug 18.

20.

Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation.

Gogada R, Prabhu V, Amadori M, Scott R, Hashmi S, Chandra D.

J Biol Chem. 2011 Aug 19;286(33):28749-60. doi: 10.1074/jbc.M110.202440. Epub 2011 Jun 28.

Supplemental Content

Support Center